Clinical Trials
2
Active:0
Completed:2
Trial Phases
2 Phases
Phase 1:1
Phase 2:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials
Phase 1
1 (50.0%)Phase 2
1 (50.0%)Evaluation of the Safety and Pharmacokinetics of MSI-195 to a Commercial S-Adenosylmethionine
- First Posted Date
- 2020-11-10
- Last Posted Date
- 2020-11-10
- Lead Sponsor
- MSI Methylation Sciences, Inc.
- Target Recruit Count
- 34
- Registration Number
- NCT04623034
Add-On Study of MSI-195 (S-Adenosyl-L-Methionine, SAMe) for Patients With Major Depressive Disorder (MDD)
- First Posted Date
- 2013-07-31
- Last Posted Date
- 2016-03-18
- Lead Sponsor
- MSI Methylation Sciences, Inc.
- Target Recruit Count
- 376
- Registration Number
- NCT01912196
- Locations
- 🇺🇸
MSI Investigational Site, Bellevue, Washington, United States
🇺🇸MSI INvestigational Site, Kissimmee, Florida, United States
News
No news found